Find More Contacts for Turning Point Therapeutics
Athena Countouriotis
CEO, President
Executive Management
1 email found 1 phone number found
View contacts for Turning Point Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email
  • Phone Number (858)926-5251

Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential

targets regulating the tumor microenvironment and tumor immunity.

Lists Featuring This Company

San Diego Biotechnology Companies
636 Number of Organizations ? $29.2B Total Funding Amount ? 1,561 Number of Investors
Biotechnology Companies (Top 10K)
9,958 Number of Organizations ? $619.8B Total Funding Amount ? 38,139 Number of Investors
West Coast Biotechnology Companies
4,133 Number of Organizations ? $169.2B Total Funding Amount ? 10,420 Number of Investors
West Coast Acquired Companies (Top 10K)
9,965 Number of Organizations ? $220.8B Total Funding Amount ? 24,086 Number of Investors
Turning Point Therapeutics was acquired by Bristol Myers Squibb for $4.1B on Jun 3, 2022. This deal was done in Cash.

Frequently Asked Questions

Where is Turning Point Therapeutics's headquarters? Turning Point Therapeutics is located in San Diego, California, United States.Who invested in Turning Point Therapeutics? Turning Point Therapeutics has 11 investors including Lilly Asia Ventures and HBM Healthcare Investments AG.How much funding has Turning Point Therapeutics raised to date? Turning Point Therapeutics has raised $1.2B.When was the last funding round for Turning Point Therapeutics? Turning Point Therapeutics closed its last funding round on Oct 26, 2020 from a Post-IPO Equity round.